Immunotherapy of leukemia--a realistic clinical possibility?
Gahrton, G.
Lakartidningen 68(14): 1601-1608
1971
ISSN/ISBN: 0023-7205 PMID: 4930453 Document Number: 31031
Document emailed within 1 workday
Related Documents
Kehlet, H.; Højgaard, L. 2004: The bed-less hospital--a realistic possibility? Ugeskrift for Laeger 166(51): 4706-4707Maeda, Y.; Horiuchi, F.; Morita, S.; Matsuda, M.; Shirakawa, C.; Masaki, H.; Koyama, A.; Hamazaki, H.; Fujimoto, T.; Irimajiri, K. 1994: Detection of minimal residual disease using clonospecific primers for CDRIIi in patients with acute B lymphocytic leukemia with or without Philadelphia chromosome: possibility of clinical application as a tool for improving prognosis Experimental Hematology 22(9): 881-887
Amiel, J.L. 1970: Immunotherapy of leukemia Bruxelles Medical 50(3): 185-194
Lynn, T.C.; Metzgar, R.S. 1980: Immunotherapy of Friend leukemia with antiserum Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 13(1): 94-104
Sokal, J.E.; Aungst, C.W.; Grace, J.T. 1973: Immunotherapy in well-controlled chronic myelocytic leukemia New York State Journal of Medicine 73(10): 1180-1185
Mathé, G.; Halle-Pannenko, O.; Bourut, C. 1973: Active immunotherapy in spontaneous leukemia of AkR mice Experimental Hematology 1(2): 110-114
Dopatka, H.D.; Majer, M.; Hennessen, W.; Mauler, R. 1977: Interference of preceding BCG vaccination with BCG immunotherapy in L2C-guinea pig leukemia Developments in Biological Standardization 38: 359-362
Matthews, D.C. 1998: Immunotherapy in acute myelogenous leukemia and myelodysplastic syndrome Leukemia 12(Suppl 1): S33-S36
Vogt, W.; Braun, S.L.; Hanssmann, F.; Liebl, F.; Berchtold, G.; Blaschke, H.; Eckert, M.; Hoffmann, G.E.; Klose, S. 1994: Realistic modeling of clinical laboratory operation by computer simulation Clinical Chemistry 40(6): 922-928
Mathe, G. 1972: Chemotherapy and attempts at immunotherapy in treatment of acute lymphoid leukemia Revue Medicale de la Suisse Romande 92(6): 429-437
Udén, A.M.; Palmblad, J.; Venizelos, N. 1982: Neutrophil function during immunotherapy for acute myelogenous leukemia in remission Nouvelle Revue Francaise d'Hematologie 24(4): 231-235
Aurich, G. 1976: Effect of immunotherapy on lymphocyte function in acute lymphatic leukemia Folia Haematologica 103(6): 817-825
Leone, G.; Mango, G.; Alfano, G. 1978: Disseminated intravascular coagulation in acute promyelocytic leukemia. Possibility of treatment with glucocorticoids at high doses Nouvelle Revue Francaise d'Hematologie 20(3): 395-401
Shorin, V.A.; Bazhanov, V.S. 1974: Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics Antibiotiki 19(8): 679-684
Ouyang, H.; Meyer, K.; Maitra, P.; Daly, S.; Svoboda, R.M.; Farberg, A.S.; Rigel, D.S. 2018: Realistic Sunscreen Durability: a Randomized, Double-blinded, Controlled Clinical Study Journal of Drugs in Dermatology: Jdd 17(1): 116-117
Parrado, A.; Casares, S.; Carmona, M.; Campo, T.; Rodríguez Fernández, J.M. 1994: Immunotherapy with interleukin-2 and allogenic LAK cells in a patient with acute myeloblastic leukemia Sangre 39(5): 393-396
Mathé, G.; Hayat, M.; Amiel, J.L.; Schwarzenberg, L.; Schneider, M.; Pouillart, P.; Cattan, A. 1971: Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man Bollettino dell'Istituto Sieroterapico Milanese 50(4): 251-259
Suvatte, V.; Mahasandana, C.; Tanphaichitr, V.S.; Tuchinda, S.; Vootiprux, V. 1981: Combination of chemotherapy, radiotherapy and immunotherapy for acute lymphoblastic leukemia in children Journal of the Medical Association of Thailand 64(4): 180-191
Landewé, R.; van de Heijde, D. 2003: Is radiographic progression a realistic outcome measure in clinical trials with early inflammatory arthritis? Clinical and Experimental Rheumatology 21(5 Suppl 31: S37-S41
Esposito, L.; Benedetto, N.; Guerriero, A. 1980: Data on the immunological profile of children with acute lymphoblastic leukemia treated by immunotherapy La Pediatria 88(4): 521-531